Controversies in metastatic prostate cancer
Thematic Session 17
-
Location:Room Stockholm, North Hall (Level 1)
-
Chair:
-
Aims and objectives of this session This session will summarise most recent developments in castration sensitive and castration resistant metastatic prostate cancer. In particular, surgical resection of oligometastatic disease, new biomarkers and targets are to be discussed as part of individualised patient care. Furthermore, the upcoming role of immunotherapy in prostate cancer will be presented.
748
Institutes: University of California Davis, Dept. of Urology, Sacramento, United States of America